Search Results

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it has appointed Doug Rice as the Company’s Chief Financial Officer, effective today.

Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

Mercury Bio, (www.mercurybio.com) a Santa Fe, NM-based biotech company commercializing an innovative and highly disruptive drug delivery platform

Pfizer is proud to announce that it is supporting a McMaster University-led study, through the Ontario Clinical Oncology Group, that aims to improve care for Canadians living with multiple myeloma.

Kytopen, a leading biotechnology company specializing in scalable gene editing platforms, today announces a strategic collaboration with Rice University’s prestigious Omid Veiseh Laboratory.

The new Rice Biotech Launch Pad aims to harness local resources to grease the skids of innovation, from the lab to the clinic.

University Cancer & Blood Center, a leading oncology and hematology practice for Northeast Georgia, and University Health Alliance, a multi-disciplinary practice focusing on prevention and coordinated care, announce the opening of their High-Risk GI Clinic.

Valent BioSciences LLC and Kansas State University, Manhattan, Kansas, announce a formal long-term agreement to advance critical research in the areas of soil health and carbon smart farming. Kansas State University Distinguished Professor of Soil Microbiology, Dr. Charles W. Rice, a world-renowned researcher in carbon cycling and climate change, will oversee this initiative.